C4 THERAPEUTICS INC (CCCC)
US12529R1077 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to CCCC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 18.87. This target is 191.65% above the current price.
CCCC was analyzed by 15 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about CCCC.
In the previous month the buy percentage consensus was at a similar level.
CCCC was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-02-26 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-02-23 | Stifel | Reiterate | Buy -> Buy |
| 2024-01-29 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2023-12-13 | Stifel | Upgrade | Hold -> Buy |
| 2023-11-06 | Morgan Stanley | Upgrade | Underweight -> Equal-Weight |
| 2023-11-03 | BMO Capital | Maintains | Outperform -> Outperform |
| 2023-11-02 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-10-09 | B of A Securities | Maintains | Neutral -> Neutral |
| 2023-08-09 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-05-30 | Evercore ISI Group | Maintains | Outperform |
| 2023-05-12 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2023-05-08 | HC Wainwright & Co. | Maintains | Buy |
| 2023-03-28 | B of A Securities | Maintains | Neutral |
| 2023-02-27 | Morgan Stanley | Maintains | Underweight |
| 2023-02-24 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2023-02-24 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-03 | Wells Fargo | Maintains | Equal-Weight |
| 2022-11-08 | Wells Fargo | Maintains | Equal-Weight |
| 2022-11-04 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2022-10-11 | Morgan Stanley | Initiate | Underweight |
| 2022-05-09 | HC Wainwright & Co. | Maintains | Buy |
| 2022-04-28 | Credit Suisse | Initiate | Underperform |
| 2022-04-18 | UBS | Maintains | Buy |
| 2022-04-11 | BMO Capital | Maintains | Outperform |
| 2022-03-10 | JP Morgan | Initiate | Overweight |
| 2022-02-10 | Wells Fargo | Initiate | Equal-Weight |
| 2021-11-23 | B of A Securities | Initiate | Buy |
| 2021-10-14 | SVB Leerink | Initiate | Outperform |
| 2021-09-30 | Stifel | Initiate | Hold |
| 2021-06-24 | Brookline Capital | Initiate | Buy |